Annual Review of Biomedical Engineering

The Annual Review of Biomedical Engineering (ISSN 1523-9829) is a prestigious, invitation-based review journal published annually by Annual Reviews in the United States, dedicated to synthesizing the most significant advancements in the field of biomedical engineering. Recognized for its high academic standards and authoritative reputation, the journal is indexed in the Science Citation Index (SCI) and consistently ranks within the top tier of the Engineering and Technology category in the Chinese Academy of Sciences (CAS) journal rankings, typically securing a Zone 1 or Zone 2 position. With an impact factor of 11.3 in 2022, it serves as a critical resource for researchers, clinicians, and students seeking comprehensive insights into key research areas such as biomaterials, medical imaging, biomechanics, tissue engineering, and nanomedicine. Although the journal is not open access and primarily features invited reviews rather than original research, its rigorous editorial process ensures that the published content provides high-quality, authoritative overviews that define the current state of the discipline, despite the inherent challenges associated with the timeliness and potential redundancy of review topics.